Management in Medistim ASA purchases shares
Medistim ASA (MEDI) · publisert 13. november 2023 kl. 15:09 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Roger Morberg | VP sales APAC | Kjøp | 3 410 | 161,67 NOK | 13. november 2023 | – | – |
| Ole Arne Eiksund | Chief Business Development Officer | Kjøp | 3 410 | 161,67 NOK | 13. november 2023 | – | – |
| Ole Jørgen Robsrud | CEO in Medistim Norge AS | Kjøp | 1 237 | 161,67 NOK | 13. november 2023 | – | – |
| Hæge Wetterhus | VP Marketing | Kjøp | 928 | 161,67 NOK | 13. november 2023 | – | – |
| Stephanie Stenhagen | VP Sales EMEA | Kjøp | 247 | 161,67 NOK | 13. november 2023 | – | – |
| Håkon Grøthe | VP Innovation | Kjøp | 3 410 | 161,67 NOK | 13. november 2023 | – | – |
| Thomas Jakobsen | CFO | Kjøp | 4 547 | 161,67 NOK | 13. november 2023 | – | – |
Meldingstekst
Management in Medistim ASA has the 13th of November purchased shares form Medistim
ASA. This is part of the company long term incentive plan approved by the
general meeting the 24th of April 2023. Price per share was NOK 161,67. The
following members of management has purchased shares:
VP sales APAC Roger Morberg purchased 3410 shares and has 16259 shares after the purchase.
Chief Business Development Officer Ole Arne Eiksund purchased 3410 shares and has 5872 shares after the purchase.
CEO in Medistim Norge AS Ole Jørgen Robsrud purchased 1237 shares and has 3442 shares after the purchase.
VP Marketing Hæge Wetterhus purchased 928 shares and has 1591 shares after the purchase.
VP Sales EMEA Stephanie Stenhagen purchased 247 shares and has 557 shares after the purchase.
VP Innovation Håkon Grøthe purchased 3410 shares and has 7821 shares after the purchase.
CFO Thomas Jakobsen purchased 4547 shares and has 30526 shares after the purchase.
Medistim ASA has sold 17189 shares and has 57843 own shares after the sale.